Alpine Immune Sciences Inc (NAS:ALPN)
$ 64.94 0.12 (0.19%) Market Cap: 4.45 Bil Enterprise Value: 4.16 Bil PE Ratio: 0 PB Ratio: 11.95 GF Score: 61/100

Q3 2020 Alpine Immune Sciences Inc Earnings Call Transcript

Nov 12, 2020 / 09:30PM GMT
Release Date Price: $8.16 (+2.00%)
Operator

Good afternoon, ladies and gentlemen. Thank you for joining the Alpine Immune Sciences' third-quarter 2020 financial results and corporate update conference call. (Operator Instructions) As a reminder, this conference is being recorded today, Thursday, November 12, 2020.

I would now like to introduce Laurence Watts, Investor Relations. Please go ahead.

Laurence Watts
Alpine Immune Sciences Inc - IR

Thank you, Jerome. With me on today's call from Alpine Immune Sciences are Executive Chairman and CEO, Dr. Mitchell Gold; President and Head of Research & Development, Dr. Stanford Peng; Chief Financial Officer, Paul Rickey; and Senior Vice President of Business Development and Corporate Strategy, Remy Durand.

This afternoon, Alpine Immune Sciences issued a press release announcing the company's third-quarter 2020 financial results and corporate updates. If you have not received this news release and would like to read it, or you would simply like to be added to the company's distribution list, you can do both on the Investor Relations page of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot